Based on these data, we collected serum from 22 RDEB patients and found a relative increase in the total circulating TGF-β to aberrantly high levels in all the samples relative to healthy controls in which active TGF-β1 peptide was practically undetectable. Here, TGFB1 is linked to recessive dystrophic epidermolysis bullosa.